Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells 5,318 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 5,318 shares of Intuitive Surgical stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the transaction, the executive vice president now owns 298 shares of the company’s stock, valued at approximately $110,456.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Myriam Curet also recently made the following trade(s):

• On Friday, March 1st, Myriam Curet sold 1,605 shares of Intuitive Surgical stock. The stock was sold at an average price of $383.48, for a total transaction of $615,485.40.
• On Monday, February 12th, Myriam Curet sold 481 shares of Intuitive Surgical stock. The stock was sold at an average price of $386.09, for a total transaction of $185,709.29.
• On Friday, January 26th, Myriam Curet sold 4,318 shares of Intuitive Surgical stock. The stock was sold at an average price of $370.15, for a total transaction of $1,598,307.70.

Intuitive Surgical Trading Down 0.7 %

ISRG traded down $2.65 during trading on Wednesday, hitting $374.43. 720,156 shares of the company’s stock were exchanged, compared to its average volume of 1,664,440. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $403.76. The stock has a 50 day moving average price of $386.54 and a 200 day moving average price of $344.98. The firm has a market cap of $132.81 billion, a P/E ratio of 67.59, a price-to-earnings-growth ratio of 4.65 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.00 earnings per share. Analysts forecast that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. OFI Invest Asset Management acquired a new stake in shares of Intuitive Surgical during the third quarter worth $25,000. Baystate Wealth Management LLC increased its holdings in shares of Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares during the period. MCF Advisors LLC increased its holdings in shares of Intuitive Surgical by 108.1% in the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 40 shares during the period. Headinvest LLC acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth about $28,000. Finally, Able Wealth Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth about $28,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the stock. Mizuho boosted their price objective on shares of Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. Piper Sandler boosted their price objective on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research report on Friday, April 19th. Truist Financial boosted their price objective on shares of Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a research report on Wednesday, January 24th. Finally, Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $396.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.